LAVA Medtech Shares Outstanding vs. Current Ratio

LVACDelisted Stock  USD 10.44  0.00  0.00%   
Considering the key profitability indicators obtained from LAVA Medtech's historical financial statements, LAVA Medtech Acquisition may not be well positioned to generate adequate gross income at the moment. It has a very high risk of underperforming in January. Profitability indicators assess LAVA Medtech's ability to earn profits and add value for shareholders.
For LAVA Medtech profitability analysis, we use financial ratios and fundamental drivers that measure the ability of LAVA Medtech to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well LAVA Medtech Acquisition utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between LAVA Medtech's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of LAVA Medtech Acquisition over time as well as its relative position and ranking within its peers.
  
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
Please note, there is a significant difference between LAVA Medtech's value and its price as these two are different measures arrived at by different means. Investors typically determine if LAVA Medtech is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, LAVA Medtech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

LAVA Medtech Acquisition Current Ratio vs. Shares Outstanding Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining LAVA Medtech's current stock value. Our valuation model uses many indicators to compare LAVA Medtech value to that of its competitors to determine the firm's financial worth.
LAVA Medtech Acquisition is currently regarded as number one stock in shares outstanding category among its peers. It also is currently regarded as number one stock in current ratio category among its peers . The ratio of Shares Outstanding to Current Ratio for LAVA Medtech Acquisition is about  628,759 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the LAVA Medtech's earnings, one of the primary drivers of an investment's value.

LAVA Current Ratio vs. Shares Outstanding

Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.

LAVA Medtech

Shares Outstanding

 = 

Public Shares

-

Repurchased

 = 
11.5 M
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
Current Ratio is calculated by dividing the Current Assets of a company by its Current Liabilities. It measures whether or not a company has enough cash or liquid assets to pay its current liability over the next fiscal year. The ratio is regarded as a test of liquidity for a company.

LAVA Medtech

Current Ratio

 = 

Current Asset

Current Liabilities

 = 
18.29 X
Typically, short-term creditors will prefer a high current ratio because it reduces their overall risk. However, investors may prefer a lower current ratio since they are more concerned about growing the business using assets of the company. Acceptable current ratios may vary from one sector to another, but the generally accepted benchmark is to have current assets at least as twice as current liabilities (i.e., Current Ration of 2 to 1).

LAVA Current Ratio Comparison

LAVA Medtech is currently under evaluation in current ratio category among its peers.

LAVA Medtech Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in LAVA Medtech, profitability is also one of the essential criteria for including it into their portfolios because, without profit, LAVA Medtech will eventually generate negative long term returns. The profitability progress is the general direction of LAVA Medtech's change in net profit over the period of time. It can combine multiple indicators of LAVA Medtech, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
LAVA Medtech Acquisition Corp. does not have significant operations. LAVA Medtech Acquisition Corp. is a subsidiary of LAVA Medtech Sponsor LP. Lava Medtech is traded on NASDAQ Exchange in the United States.

LAVA Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on LAVA Medtech. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of LAVA Medtech position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the LAVA Medtech's important profitability drivers and their relationship over time.

Learn to be your own money manager

Our tools can tell you how much better you can do entering a position in LAVA Medtech without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Efficient Frontier Now

   

Efficient Frontier

Plot and analyze your portfolio and positions against risk-return landscape of the market.
All  Next Launch Module

Use Investing Themes to Complement your LAVA Medtech position

In addition to having LAVA Medtech in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Target Outcome ETFs Thematic Idea Now

Target Outcome ETFs
Target Outcome ETFs Theme
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Target Outcome ETFs theme has 92 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Target Outcome ETFs Theme or any other thematic opportunities.
View All  Next Launch
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.

Other Consideration for investing in LAVA Stock

If you are still planning to invest in LAVA Medtech Acquisition check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the LAVA Medtech's history and understand the potential risks before investing.
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Volatility Analysis
Get historical volatility and risk analysis based on latest market data